Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis
- PMID: 24046295
- DOI: 10.1093/cid/cit565
Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis
Comment in
-
Reply to Mikulska et al.Clin Infect Dis. 2013 Dec;57(12):1787-8. doi: 10.1093/cid/cit568. Epub 2013 Sep 17. Clin Infect Dis. 2013. PMID: 24046297 Free PMC article. No abstract available.
Comment on
-
The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis.Clin Infect Dis. 2013 Oct;57(7):1001-4. doi: 10.1093/cid/cit393. Epub 2013 Jun 11. Clin Infect Dis. 2013. PMID: 23759343 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources